Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT

Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT

Bone Marrow Transplantation (2003) 31, 1065. doi:10.1038/sj.bmt.1704079

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bone marrow transplantation (Basingstoke) 2003-06, Vol.31 (11), p.1065-1065
Hauptverfasser: Pitini, V, Arrigo, C, Aloi, G, Micali, C, La Gattuta, G
Format: Artikel
Sprache:eng
Schlagworte:
Antineoplastic Agents - therapeutic use
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Care and treatment
Cell Biology
Complications and side effects
correspondence
Dexamethasone
Dosage and administration
Doxorubicin
Hematology
Hematopoietic Stem Cell Mobilization - methods
Hematopoietic Stem Cell Transplantation
Hematopoietic stem cells
Humans
Internal Medicine
Medicine
Medicine & Public Health
Melphalan - therapeutic use
Multiple myeloma
Multiple Myeloma - drug therapy
Multiple Myeloma - therapy
Public Health
Salvage Therapy - methods
Stem cell transplantation
Stem Cells
Thalidomide
Thalidomide - therapeutic use
Transplantation
Vincristine
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Bone Marrow Transplantation (2003) 31, 1065. doi:10.1038/sj.bmt.1704079
ISSN:0268-3369
1476-5365
DOI:10.1038/sj.bmt.1704079